Drug Discovery and Development Based on Quantitative Systems Pharmacology (QSP)

Drug Discovery and Development Based on Quantitative Systems Pharmacology (QSP)

  • Home
  • About UPDDI
    • Programs
      • Liver Diseases
      • Metastatic Cancer
      • Neurodegenerative Diseases
    • Projects
      • Tissue Chip Testing Center
      • Acute Kidney Injury
      • Acute Pancreatitis
      • Mcm2-7 Replicative Helicase
      • Autosomal Dominant Leukodystrophy
      • MAP Kinase Phosphatases in Cancer and Heart Regeneration
      • Malignant Gliomas
      • Melatonin for Neuroprotection
    • Technical Strengths
      • Discovery Technologies
      • Chemistry/Medicinal Chemistry
      • Early Safety Assessment
      • Computational Chemistry
      • Computational Biology
      • Preclinical ADME/Tox & Rodent Efficacy
    • Collaborations
  • Environment
    • Drug Discovery Education
    • Facilities
      • Discovery Technology
      • Chemistry/Medicinal Chemistry
      • Computational Biology & Chemistry
      • Zebrafish Facility
      • Preclinical Resources
  • People
    • Director/Associate Directors
    • Internal Advisory Board
    • External Advisory Board
    • Leadership Faculty
    • Team Members
  • News + Events
    • News
    • Events
  • Publications
  • Microphysiology Systems Database
  • Contact Us
    • Positions Available
    • Giving
MENUMENU
  • Home
  • About UPDDI
    • Programs
      • Liver Diseases
      • Metastatic Cancer
      • Neurodegenerative Diseases
    • Projects
      • Tissue Chip Testing Center
      • Acute Kidney Injury
      • Acute Pancreatitis
      • Mcm2-7 Replicative Helicase
      • Autosomal Dominant Leukodystrophy
      • MAP Kinase Phosphatases in Cancer and Heart Regeneration
      • Malignant Gliomas
      • Melatonin for Neuroprotection
    • Technical Strengths
      • Discovery Technologies
      • Chemistry/Medicinal Chemistry
      • Early Safety Assessment
      • Computational Chemistry
      • Computational Biology
      • Preclinical ADME/Tox & Rodent Efficacy
    • Collaborations
  • Environment
    • Drug Discovery Education
    • Facilities
      • Discovery Technology
      • Chemistry/Medicinal Chemistry
      • Computational Biology & Chemistry
      • Zebrafish Facility
      • Preclinical Resources
  • People
    • Director/Associate Directors
    • Internal Advisory Board
    • External Advisory Board
    • Leadership Faculty
    • Team Members
  • News + Events
    • News
    • Events
  • Publications
  • Microphysiology Systems Database
  • Contact Us
    • Positions Available
    • Giving

QSP is the New Vision of Drug Discovery and Development for Precision Medicine

Optimizing the discovery and development of new molecular entities through collaborations between faculty, academic centers, corporations and government agencies, together with innovations focused on Quantitative Systems Pharmacology (QSP).

Harnessing MPS for QSP, Handbook

QSP In Drug Discovery

Highlights

  • Liver Diseases
  • Metastatic Cancers
  • Neurodegenerative Diseases
  • QSP Technology Development
  • Projects
  • Department of Computational and Systems Biology

News

November 11, 2019

Lawrence Vernetti, Keynote speaker at the 5th International Conference on Drug Discovery, Development and Lead Optimization, November 21-23, 2019, Boston, MA (Drug Discovery-2019).

November 11, 2019

Albert Gough presenting at the 2019 Organ on a Chip World Congress, October 15, 2019, San Diego, CA.

November 11, 2019

Publication: Applications of the Microphysiology Systems Database for Experimental ADME-Tox and Disease Models. bioRxiv, September 25, 2019

November 11, 2019

D. Lansing Taylor, PhD presenting at the 3D Tissue Models meeting, September 4-6, 2019, Boston, MA.

« Previous 1 2 3 4 5 … 15 Next »

Copyright © 2021 University of Pittsburgh Drug Discovery Institute

WordPress Image Lightbox Plugin